Generics 11

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tolvaptan manufacturers

11 products found

Filters

tolvaptan

Tablets, film coated 7.5 mg, 15 mg, 30 mg, 45 mg, 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Iceland
GMP approvals
EU GMP
Manufacturer #28915
This company specializes in generic pharmaceuticals within the EU region. They offer out-licensing and contract manufacturing services to pharmaceutical companies seeking high-quality production from a reliable European partner. Their facility utilizes green energy sources, highlighting their commitment to sustainability. While specific therapy areas and product details are not provided, they likely focus on various dosage forms common in generic pharmaceuticals. The company emphasizes its skilled workforce and dedication to employee well-being.

Manufacturer usually replies in 10 days

tolvaptan

Tablets, immediate release (IR) 15 mg, 30 mg, 45 mg, 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref. Jinarc Dossier availability date: Q3 2025
Manufacturer #31058
This company, based in Europe, is a pharmaceutical manufacturer with a history spanning over seven decades. They focus on the development, production, and marketing of generic and value-added medicines, catering to patients globally. Their expertise lies in complex generics and their portfolio includes prescription drugs and over-the-counter medications. They hold significant experience in the industry, with strong manufacturing capabilities in Europe and North America, backed by GMP certifications. The company has a robust track record of growth, demonstrated by its international presence and expansion into key regions such as Europe and North America. Key therapy areas include cardiovascular, oncology, and gastrointestinal disorders. Their production lines include solid dosage forms, injectables, and liquids.

Manufacturer usually replies in 8 days

tolvaptan

Tablets, immediate release (IR) 7.5 mg, 15 mg, 30 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref. Samsca Dossier availability date: Q3 2025
Manufacturer #31058
This company, based in Europe, is a pharmaceutical manufacturer with a history spanning over seven decades. They focus on the development, production, and marketing of generic and value-added medicines, catering to patients globally. Their expertise lies in complex generics and their portfolio includes prescription drugs and over-the-counter medications. They hold significant experience in the industry, with strong manufacturing capabilities in Europe and North America, backed by GMP certifications. The company has a robust track record of growth, demonstrated by its international presence and expansion into key regions such as Europe and North America. Key therapy areas include cardiovascular, oncology, and gastrointestinal disorders. Their production lines include solid dosage forms, injectables, and liquids.

Manufacturer usually replies in 8 days

Want to see all 11 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Tolvaptan Manufacturers

Tolvaptan belongs to a class of medications called vasopressin V2 receptor antagonist. This drug is used to treat low sodium levels in the blood in people who have heart failure as they have higher serum levels of vasopressin, syndrome of inappropriate antidiuretic hormone or hormone imbalance and cirrhosis. Tolvaptan improves urine flow without causing the body to lose too much sodium during urination. Tolvaptan is advised as a prescription product, generic prescription product as well as mixture product. Tolvaptan manufacturers sell this Drug under the Brand name of drug Jynarque, Samsca. This drug is available in dosage form of tablet which comes in 15 mg and 30 mg dosage strengths. The tolvaptan 15 mg tablet is blue, triangular, debossed with manufacturer’s name on one side and dosage strength on the other, whereas the tolvaptan 30 mg tablet is blue, round, debossed with manufacturer’s name on one side, and dosage strength on the other. Tolvaptan tablet is taken by mouth with or without food. Before using this medication, the risk of taking the drug must be weighed against the benefits it provides. It is always recommended to consult a physician before taking Tolvaptan as this medication may interact with other drugs and few drugs can affect the removal of the tolvaptan from the body and affects its working. The usual initial dose for Tolvaptan in adults suffering from hyponatremia (abnormal sodium levels in the blood) is 15 mg administered once daily, and the dose can be increased to 30 mg once daily after at least a day to a maximum of 60 mg once daily as required to achieve the desired level of sodium in the blood. Tolvaptan should not be administered for more than 30 days. This medication is not recommended for pediatric use as safety and efficacy have not been established. Tolvaptan tablets are recommended to store at 25° C (77° F), with excursions permitted between 15° C and 30° C (59° F - 86° F)

Wholesale Price of Tolvaptan

The wholesale price for 10 units of 30 mg Tolvaptan oral tablets is in between $ 3831.85 - 4110.79 with per unit cost comes at $ 383.19 - $ 411.08. Brand drug of tolvaptan is categorized under patient assistance programs where the medication is sponsored by pharmaceutical companies or the manufacturer where the drug is provided for free or at discounted rates to low-income or underinsured people who fulfill the eligibility requirement.

Tolvaptan - Mechanism of Action

Tolvaptan is a vasopressin V2 receptor antagonist, vasopressin acts on the V2 receptors and blocks it. By blocking V2 receptors in the renal collecting ducts it prevents water absorption. This action ultimately results in an increase in urine volume and increases electrolyte-free water clearance to reduce intravascular volume and increases serum sodium levels. Tolvaptan works by increasing the amount of water released from the body as urine, removing fluid from the body helps in increasing the level of sodium in the blood.

Finding Tolvaptan Manufacturers and Suppliers

Many times we tend to find manufacturers and suppliers by attending conferences, exhibitions, etc. that is time-consuming and is directly related to finance, and we are not sure whether we get the trusted suppliers, which is a major constraint then. One can avoid this constraint by Pipelinepharma, which helps buyers in finding the trusted manufacturers and suppliers of Tolvaptan. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products which quickly connects owner with the consumer for the business development. One can filter the product names in unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible